Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 16, 2023

SELL
$109.73 - $128.47 $78,018 - $91,342
-711 Reduced 2.82%
24,469 $2.74 Million
Q2 2023

Aug 08, 2023

SELL
$114.69 - $141.28 $27,869 - $34,331
-243 Reduced 0.96%
25,180 $3.03 Million
Q1 2023

Apr 17, 2023

SELL
$131.13 - $159.06 $12,588 - $15,269
-96 Reduced 0.38%
25,423 $3.52 Million
Q4 2022

Jan 19, 2023

SELL
$125.64 - $157.68 $332,946 - $417,852
-2,650 Reduced 9.41%
25,519 $0
Q3 2022

Oct 18, 2022

BUY
$115.11 - $142.29 $74,015 - $91,492
643 Added 2.34%
28,169 $3.42 Million
Q2 2022

Aug 08, 2022

SELL
$112.71 - $135.93 $450 - $543
-4 Reduced 0.01%
27,526 $3.27 Million
Q1 2022

Apr 21, 2022

BUY
$126.0 - $156.48 $276,696 - $343,630
2,196 Added 8.67%
27,530 $3.64 Million
Q4 2021

Jan 25, 2022

BUY
$147.95 - $164.3 $428,759 - $476,141
2,898 Added 12.92%
25,334 $4.05 Million
Q3 2021

Nov 03, 2021

SELL
$147.58 - $179.28 $257,674 - $313,022
-1,746 Reduced 7.22%
22,436 $3.53 Million
Q2 2021

Jul 28, 2021

BUY
$127.69 - $148.81 $71,761 - $83,631
562 Added 2.38%
24,182 $3.57 Million
Q1 2021

May 05, 2021

BUY
$114.99 - $130.12 $2.72 Million - $3.07 Million
23,620 New
23,620 $3 Million
Q4 2020

Feb 09, 2021

SELL
$100.01 - $119.3 $420,542 - $501,656
-4,205 Closed
0 $0
Q3 2020

Oct 20, 2020

BUY
$88.11 - $103.42 $10,396 - $12,203
118 Added 2.89%
4,205 $424,000
Q2 2020

Jul 20, 2020

BUY
$68.92 - $91.14 $26,809 - $35,453
389 Added 10.52%
4,087 $361,000
Q1 2020

May 12, 2020

BUY
$63.37 - $90.13 $234,342 - $333,300
3,698 New
3,698 $265,000
Q4 2019

Feb 04, 2020

SELL
$72.49 - $85.45 $270,097 - $318,386
-3,726 Closed
0 $0
Q2 2019

Aug 01, 2019

BUY
$66.89 - $81.94 $249,232 - $305,308
3,726 New
3,726 $278,000

Others Institutions Holding A

About AGILENT TECHNOLOGIES, INC.


  • Ticker A
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 296,040,992
  • Market Cap $40.1B
  • Description
  • Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...
More about A
Track This Portfolio

Track Stanley Laman Group, Ltd. Portfolio

Follow Stanley Laman Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stanley Laman Group, Ltd. with notifications on news.